Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients.
Doualla-Bell F, Gaseitsiwe S, Ndungú T, Modukanele M, Peter T, Novitsky V, Ndwapi N, Tendani G, Avalos A, Wester W, Bussmann H, Cardiello P, Marlink R, Moffat H, Thior I, Wainberg MA, Essex M. Doualla-Bell F, et al. Among authors: cardiello p. Antivir Chem Chemother. 2004 Jul;15(4):189-200. doi: 10.1177/095632020401500402. Antivir Chem Chemother. 2004. PMID: 15457680 Free article.
Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.
Wester CW, Kim S, Bussmann H, Avalos A, Ndwapi N, Peter TF, Gaolathe T, Mujugira A, Busang L, Vanderwarker C, Cardiello P, Johnson O, Thior I, Mazonde P, Moffat H, Essex M, Marlink R. Wester CW, et al. Among authors: cardiello p. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):336-43. doi: 10.1097/01.qai.0000159668.80207.5b. J Acquir Immune Defic Syndr. 2005. PMID: 16249709
Strengthening healthcare capacity through a responsive, country-specific, training standard: the KITSO AIDS training program's support of Botswana's national antiretroviral therapy rollout.
Bussmann C, Rotz P, Ndwapi N, Baxter D, Bussmann H, Wester CW, Ncube P, Avalos A, Mine M, Mabe E, Burns P, Cardiello P, Makhema J, Marlink R. Bussmann C, et al. Among authors: cardiello p. Open AIDS J. 2008;2:10-6. doi: 10.2174/1874613600802010010. Epub 2008 Feb 29. Open AIDS J. 2008. PMID: 18923699 Free PMC article.
Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study.
Cardiello PG, van Heeswijk RP, Hassink EA, Srasuebkul P, Mahanontharit A, Samor TM, Worarien W, Beijnen JH, Hoetelmans RM, Ruxrungtham K, Cooper DA, Lange JM, Phanuphak P. Cardiello PG, et al. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):464-70. doi: 10.1097/00042560-200204150-00006. J Acquir Immune Defic Syndr. 2002. PMID: 11981362 Clinical Trial.
Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.
Ungsedhapand C, Srasuebkul P, Cardiello P, Ruxrungtham K, Ratanasuwan W, Kroon ED, Tongtalung M, Juengprasert N, Ubolyam S, Siangphoe U, Emery S, Lange JM, Cooper DA, Phanuphak P; HIV-NAT 002 and HIV-NAT 003 Study Team. Ungsedhapand C, et al. Among authors: cardiello p. J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):693-701. doi: 10.1097/00126334-200406010-00006. J Acquir Immune Defic Syndr. 2004. PMID: 15167288 Clinical Trial.
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study.
Ananworanich J, Siangphoe U, Hill A, Cardiello P, Apateerapong W, Hirschel B, Mahanontharit A, Ubolyam S, Cooper D, Phanuphak P, Ruxrungtham K. Ananworanich J, et al. Among authors: cardiello p. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):523-9. J Acquir Immune Defic Syndr. 2005. PMID: 16044002 Clinical Trial.
14 results